SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017162
Filing Date
2019-05-08
Accepted
2019-05-08 16:00:57
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20190331.htm 10-Q 1413801
2 EX-10.1 scyx-ex101_41.htm EX-10.1 780293
3 EX-31.1 scyx-ex311_8.htm EX-31.1 15626
4 EX-31.2 scyx-ex312_6.htm EX-31.2 15591
5 EX-32.1 scyx-ex321_7.htm EX-32.1 9415
  Complete submission text file 0001564590-19-017162.txt   7681541

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scyx-20190331.xml EX-101.INS 1830903
7 XBRL TAXONOMY EXTENSION SCHEMA scyx-20190331.xsd EX-101.SCH 42468
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20190331_cal.xml EX-101.CAL 50729
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20190331_def.xml EX-101.DEF 144468
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20190331_lab.xml EX-101.LAB 385633
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20190331_pre.xml EX-101.PRE 297141
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 19806531
SIC: 2834 Pharmaceutical Preparations